Please sign in to follow a disease.
Can a structured recovery program help older knee replacement patients bounce back faster?
NCT ID NCT07828418
First seen Sep 18, 2026 · Last updated Sep 21, 2026 · Updated 1 time
Summary
Researchers are studying whether a structured Enhanced Recovery After Surgery (ERAS) care pathway improves pain, knee function, and physical resilience in adults aged 65 and older who have total knee replacement. The ERAS pathway includes preoperative assessment and education, nutritional checks, multimodal pain management, keeping patients warm during surgery, early eating and walking, and early rehabilitation. Participants receive either the ERAS pathway or the hospital's usual perioperative care. The study measures pain, knee function, and physical resilience before surgery and at several points afterward, along with vital signs, hospital stay length, and time to first walking.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Enhanced Recovery After Surgery (ERAS) care pathway, a structured program of preoperative assessment, pain control, early eating and walking, and rehabilitation
- What this could lead to
- If the ERAS pathway helps, it could become a standard way to speed recovery and reduce pain for older adults having knee replacement surgery.
- What could go wrong
- This is a small study of 60 people at one hospital, so results may not apply broadly. Recovery can vary widely between individuals, and the ERAS approach may not outperform usual care for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
65 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Aged 65 years or older * Scheduled to undergo primary unilateral elective total knee arthroplasty (TKA) * Conscious and able to communicate in Mandarin Chinese or Taiwanese * Willing to complete the study questionnaires and provide written informed consent Exclusion Criteria: * Cognitive impairment (e.g., moderate or severe dementia) or psychiatric illness that prevents adequate understanding, communication, or study participation * Postoperative transfer to an intensive care unit, repeat surgery, or death * Withdrawal of willingness to continue study participation during the study period
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Total knee arthroplasty (replacement) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.